"The charts, as interpreted by the legendary Larry Williams, suggest that retail tends to roar every year from Thanksgiving through Christmas," Cramer said.
GM is withdrawing from litigation led by the Trump administration against California over the state being allowed to set its own emissions regulations.
While cinema owners are excited to have a family-friendly title in theaters, industry experts aren't convinced "The Croods" sequel is a box office savior.
"You cannot manufacture a talented and compassionate caregiver, and that's where we're having trouble with now," Allina Health CEO Dr. Penny Wheeler told CNBC.
Tesla hit another milestone in making the S&P 500 Index, but a rush of positive earnings reports from Chinese EV makers shows competition is heating up.
Regeneron will provide the U.S. with 300,000 doses of its newly authorized Covid-19 antibody treatment by early January, CEO Dr. Leonard Schleifer said.
U.S. stock futures rose Monday, supported by positive Covid-19 vaccine data from AstraZeneca and FDA emergency approval for Regeneron's antibody treatment.
With Thanksgiving travel curbed as a result of the CDC's warning about heightened Covid-19 risk, two traders gauge the impact on the underlying stocks.